Abstract
At the UMC Utrecht, a new Gene and Cell Therapy Facility (GCT-F) for gene and cellular therapy protocols has recently been opened and is now fully operational. The main objective for building this expensive facility was to enable translation of preclinical research into clinical protocols, with an emphasis on the preparation of genetically modified cellular products.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Verdonck LF, Dekker AW, de Gast GC, van Kempen ML, Lokhorst HM, Nieuwenhuis HK. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994;83:3090–96.
Tiberghien P. Use of suicide gene-expressing donor T-cells to control allore-activity after haematopoietic stem cell transplantation. Review in J Intern Med 2001;249:369–77.
Slaper-Cortenbach I, Simonetti E, Hagenbeek A, Ebeling S. Highly enriched, LNGF-R transduced T cell isolation procedure in a closed system using anti-biotin Microbeads and the new CliniMACSplus 5. 1 enrichment procedure. Blood 2001;98:411b.
Arts, CHP, Blankensteijn JD, Heijnen-Snyder GJ, et al. Reduction of nonendothelial cell contamination of microvascular endothelial cell seeded grafts decreases thrombogenicity and intimai hyperplasia. Eur. J. Endovasc Surg 2002;23:404–12.
Arts, Cora HP, de Groot Philip G, Heijnen-Snyder Glenda J, Blankensteijn Jan D, Eikelboom Bert C, Slaper-Cortenbach Ineke CM. Application of clinical grade CD34-mediated method for the enrichment of microvascular endothelial cells from fat tissue. Cytotherapy 2001;3:544.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Slaper-Cortenbach, I. et al. (2003). Cell Processing for Gene and Cell Therapy Protocols: Limitations and Opportunities!. In: Sibinga, C.T.S., De Leij, L.F.M.H. (eds) Cellular Engineering and Cellular Therapies. Developments in Hematology and Immunology, vol 38. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3718-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3718-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-5250-9
Online ISBN: 978-1-4757-3718-9
eBook Packages: Springer Book Archive